Experience of malignancies with oral glucose-lowering drugs in the randomised controlled ADOPT (A Diabetes Outcome Progression...
Table 4 Numbers of participants developing malignancies and selected non-malignant neoplasms in RECORD. Full size table. ... For women, breast, ovarian and uterine cancers showed no consistent trends. No additional non-serious adverse event ... Neoplasm occurrences were collected as adverse events in these studies. We reviewed and re-analysed the individual participant ... Where a term, such as breast neoplasm is ambiguous as to malignancy and no further information can be obtained, it is counted ...
Risk of extracolonic second primary cancers following a primary colorectal cancer: a systematic review and meta-analysis |...
Bright CJ, Reulen RC, Winter DL, Stark DP, McCabe MG, Edgar AB et al (2019) Risk of subsequent primary neoplasms in survivors ... uterine, thyroid, brain, female genital, and liver, hepatic duct, and biliary tract cancers, as well as melanoma, leukaemia, ... Specific details of how the expected number of neoplasms were calculated in each study have been summarised in Supplementary ...